WHO Calls for Testing Licensed Ebola Vaccine Against Bundibugyo Strain as DRC Outbreak Reaches 4,000 Cases

WHO Calls for Testing Licensed Ebola Vaccine Against Bundibugyo Strain as DRC Outbreak Reaches 4,000 Cases

On 7 August 2026, WHO recommended human trials of Ervebo — the only licensed Ebola vaccine — to test whether it protects against the Bundibugyo strain. DRC's fastest-spreading outbreak on record has hit 4,053 cases and 1,850 deaths since mid-May. Animal studies were encouraging. Gavi released 500,000 stockpiled doses, some already in DRC. WHO urged caution on expected efficacy.

Published

Read at another depth